CHRS Market Cap & Key Metrics
Coherus Oncology, Inc.
$0.55
-$0.03(-4.88%)
53
Overall
80
Value
45
Tech
34
Quality
Market Cap
$85.61M
Volume
536.14K
52W Range
$0.73 - $2.62
Target Price
$7.75
CHRS market cap is $85.61M. This page lists Coherus Oncology, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CHRS Key Metrics
- Market cap
- $85.61M
- EPS estimate, current year
- $-0.83
- EPS growth, 3-year
- +33.52%
- Value score
- 80
- Quality score
- 34
- Technical score
- 45
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $42.17M | $26.39M | $257.24M | $211.04M | $326.55M |
| EBITDA | -$170.20M | -$197.79M | -$191.53M | -$249.15M | -$260.69M |
| EPS | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CHRS | $0.55 | -4.9% | 536.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |